Johnson & Johnson JNJ
NYSE JNJ
$258.80 -5.94 (-2.24%)
As of: Oct 1, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Common Equity (2009 - 2026)

Updated

Johnson & Johnson (JNJ) posted Common Equity of $84.97 billion for Q2 2026, up 8.3% from $78.47 billion a year earlier and up 4.7% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Common Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Johnson & Johnson's Common Equity came in at $81.54 billion, up 14.1% from FY2024.

  • Annual Common Equity shows a four-year compound annual growth rate of 6.5% (FY2021 to FY2025).
  • In prior years, Johnson & Johnson's Common Equity was $71.49 billion in FY2024 (+3.9%), $68.77 billion in FY2023 (-10.5%), $76.8 billion in FY2022 and $63.28 billion in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2011.
  • On a year-over-year basis, Common Equity has increased in each of the last seven quarters, with growth averaging 7.9% over the last eight quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 14.1%; the weakest was Q4 2023, with a decline of 10.5%.
  • According to Business Quant data, Common Equity for the three prior quarters was $81.19 billion (Q1 2026), $81.54 billion (Q4 2025) and $79.28 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 84.97 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.94 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.37 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.25 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn 22.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 84.97 Bn
Mar 29, 2026 81.19 Bn
Dec 28, 2025 81.54 Bn
Sep 28, 2025 79.28 Bn
Jun 29, 2025 78.47 Bn
Mar 30, 2025 78.11 Bn
Dec 29, 2024 71.49 Bn
Sep 29, 2024 70.16 Bn
Jun 30, 2024 71.54 Bn
Mar 31, 2024 70.02 Bn
Dec 31, 2023 68.77 Bn
Oct 1, 2023 71.23 Bn
Jul 2, 2023 76.41 Bn
Apr 2, 2023 70.87 Bn
Jan 1, 2023 76.80 Bn
Oct 2, 2022 74.60 Bn
Jul 3, 2022 76.36 Bn
Apr 3, 2022 74.71 Bn
Jan 2, 2022 74.02 Bn
Oct 3, 2021 70.27 Bn
API Access

Johnson & Johnson Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY